Ginkgo Bioworks Holdings, Inc. (DNA)
Fuera de horario:
Ginkgo Bioworks Holdings, Inc.
27 Drydock Avenue
8th Floor
Boston, MA 02210
United States
877 422 5362
https://www.ginkgobioworks.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 1,292
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Dr. Jason Kelly | Founder, CEO & Director | 262.5k | N/D | 1981 |
| Dr. Reshma P. Shetty | Founder, Pres, COO & Director | 262.5k | N/D | 1981 |
| Mr. Mark E. Dmytruk | Chief Financial Officer | 465.25k | N/D | 1971 |
| Mr. Thomas Knight Jr. | Founder | N/D | N/D | N/D |
| Mr. Austin Che | Founder, Head of Strategy & Treasurer | N/D | N/D | N/D |
| Mr. Bartholomew Canton | Founder, CTO & Sec. | N/D | N/D | N/D |
| Mr. Steven P. Coen CPA | Chief Accounting Officer | N/D | N/D | N/D |
| Karen Tepichin | Gen. Counsel & Sec. | N/D | N/D | N/D |
| Ms. Anna Marie Wagner | Sr. VP of Corp. Devel. | N/D | N/D | N/D |
| Ms. Samantha Sutton | Head of People | N/D | N/D | N/D |
Descripción
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Gestión corporativa
La calificación ISS Governance QuickScore de Ginkgo Bioworks Holdings, Inc. a partir del 1 de septiembre de 2023 es 10. Las puntuaciones principales son Auditoría: 9; Junta: 6; Derechos del accionista: 10; Compensación: 9.
